Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Independent Review Committee Member Curriculum Vitae	NCIT_C125439	[A summary of the qualifications of independent review committee members, including educational and work experience.]
Source Data Verification Document	NCIT_C125433	[A document describing source data and associated verification activity.]
Clinical Trial Subject Identification Log	NCIT_C125434	[A report or log that fully identifies all clinical trial subjects screened in a clinical trial.]
Investigational Product Retest and Expiry Document	NCIT_C125435	[A document describing the batch retesting and analyses of the investigational product (IP).]
Investigational Product Device Maintenance Log	NCIT_C125436	[A record or log of activities documenting the quality and condition of medical devices used in clinical trials.]
Clinical Trial Device Review Committee	NCIT_C125430	[Committee established by the sponsor to assess, at intervals, the functioning of device; or review of specified features in relationship to study objectives or safety and efficacy of device.]
Committee	NCIT_C78508	[A group delegated to consider some matter; a self-constituted organization to promote something.]
Medical Device Report of Prior Investigations	NCIT_C125431	[A report of all prior clinical, animal, and laboratory testing of a medical device.]
Clinical Trial Medical Device Investigators Agreement	NCIT_C125432	[Non-financial agreement for medical devices between a sponsor and a clinical trial investigator documenting various responsibilities.]
Rimeporide	NCIT_C87601
Nisin A	NCIT_C87602
Telavancin	NCIT_C87603
Gallamine	NCIT_C87604
Emilium Tosylate	NCIT_C87600
Prenderol	NCIT_C87609
Oxysonium	NCIT_C87605
Pavatrine Hydrochloride	NCIT_C87606
Protein C	NCIT_C87607
Imepitoin	NCIT_C87608
Methylprednisolone Sodium Succinate	NCIT_C48004	[The sodium succinate salt of a synthetic glucocorticoid receptor agonist with immunosuppressive and anti-inflammatory effects. Methylprednisolone sodium succinate is converted into active prednisolone in the body, which activates glucocorticoid receptor mediated gene expression. This includes inducing synthesis of anti-inflammatory protein IkappaB-alpha and inhibiting synthesis of nuclear factor kappaB (NF-kappaB). As a result, proinflammatory cytokine production such as IL-1, IL-2 and IL-6 is down-regulated and cytotoxic T-lymphocyte activation is inhibited. Therefore, an overall reduction in chronic inflammation and autoimmune reactions may be achieved.]